MedTrace Logo

Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy

NCT01869218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-02-09

No results posted yet for this study

Summary

This study is aimed to determine the feasibility of obtaining and molecularly characterizing pre-treatment tumor biopsies, to determine the feasibility of obtaining and molecularly characterizing archival and post-treatment tumor biopsies, to assess molecular expression changes between archival and baseline tumor samples, and to assess molecular expression changes between tumor samples obtained at baseline and at the time of disease progression.

Conditions

  • Hematologic Neoplasms

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Lam Elaine, M.D · University of Colorado, Denver

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-02
Primary Completion
2015-08-03
Completion
2021-01-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01869218 on ClinicalTrials.gov